Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2023 -6961.0% Operating margin3 345.3% Revenue growth, 20233 Where the money goes Where each dollar of revenue went, fiscal 2023 Selling, general and admin
Research and development 5¢ $125.5K Selling, general and admin 92¢ $2.2M Interest 2¢ $57.8K Out of $39.5K in revenue.3
Financial statements
Income statement Balance sheet Cash flow
Annual Quarterly
Revenue4 5 6 7 3 $39.5K in 2023−17% since 2017 0 $200.0K $400.0K $600.0K $800.0K 2017: $47.6K $47.6K 2017 2018: $195.6K $195.6K 2018 +311% 2019: $799.5K $799.5K 2019 +309% 2020: $0 $0 2020 2021: $60.5K $60.5K 2021 2022: $8.9K $8.9K 2022 −85% 2023: $39.5K $39.5K 2023 +345% Gross profit4 5 8 $0 in 20200 $50.0K $100.0K $150.0K $200.0K 2017: $4.7K $4.7K 2017 2018: $187.1K $187.1K 2018 +3867% 2019: $0 $0 2019 2020: $0 $0 2020 Operating income4 5 8 6 7 3 -$2.8M in 2023−13% since 2017 -$15.0M -$10.0M -$5.0M 0 2017: -$3.1M -$3.1M 2017 2018: -$5.0M -$5.0M 2018 +60% 2019: -$3.1M -$3.1M 2019 −38% 2020: -$4.9M -$4.9M 2020 +59% 2021: -$14.0M -$14.0M 2021 +182% 2022: -$4.7M -$4.7M 2022 −67% 2023: -$2.8M -$2.8M 2023 −41% Net income4 5 8 6 7 3 -$8.1M in 2023+93% since 2017 -$20.0M -$15.0M -$10.0M -$5.0M 0 2017: -$4.2M -$4.2M 2017 2018: -$6.8M -$6.8M 2018 +62% 2019: -$6.4M -$6.4M 2019 −5% 2020: -$6.4M -$6.4M 2020 −1% 2021: -$16.0M -$16.0M 2021 +150% 2022: -$6.2M -$6.2M 2022 −61% 2023: -$8.1M -$8.1M 2023 +29% Revenue9 10 $17.5K in Q2 FY2024−67% since Q1 FY2024 0 $20.0K $40.0K $60.0K Q1 FY2024: $53.0K $53.0K Q1 FY2024 Q2 FY2024: $17.5K $17.5K Q2 FY2024 −67% Operating income9 10 -$569.4K in Q2 FY2024+42% since Q1 FY2024 -$600.0K -$400.0K -$200.0K 0 Q1 FY2024: -$401.6K -$401.6K Q1 FY2024 Q2 FY2024: -$569.4K -$569.4K Q2 FY2024 +42% Net income9 10 -$2.3M in Q2 FY2024+677% since Q1 FY2024 -$3.0M -$2.0M -$1.0M 0 Q1 FY2024: -$292.3K -$292.3K Q1 FY2024 Q2 FY2024: -$292.3K -$292.3K Q2 FY2024 +0% Q2 FY2024: -$2.3M -$2.3M Q2 FY2024 +677% Fiscal year 2017 2018 2019 2020 2021 2022 2023 Revenue $47.6K4 $195.6K5 $799.5K5 $06 $60.5K7 $8.9K3 $39.5K3 Cost of revenue $42.9K4 $8.5K5 $08 $08 Gross profit $4.7K4 $187.1K5 $08 $08 Research and development $1.4M4 $2.1M5 $08 $426.7K6 $284.9K10 $153.7K3 $125.5K3 Selling, general and admin $5.7M7 $4.1M3 $2.2M3 Operating income -$3.1M4 -$5.0M5 -$3.1M8 -$4.9M6 -$14.0M7 -$4.7M3 -$2.8M3 Interest $315.0K4 $456.1K5 $222.2K8 $234.8K6 $247.8K6 $57.8K11 Income tax $04 $05 $08 $06 $07 $03 $03 Net income -$4.2M4 -$6.8M5 -$6.4M8 -$6.4M6 -$16.0M7 -$6.2M3 -$8.1M3 Earnings per share -$0.108 -$0.066 $0.127 -$0.043 -$0.043 Earnings per share (diluted) -$0.108 -$0.066 $0.127 -$0.043 -$0.043
Total assets4 5 8 6 7 3 $4.1M in 2023+88% since 2017 0 $5.0M $10.0M $15.0M 2017: $2.2M $2.2M 2017 2018: $2.1M $2.1M 2018 −5% 2019: $1.7M $1.7M 2019 −19% 2020: $11.3M $11.3M 2020 +569% 2021: $5.3M $5.3M 2021 −53% 2022: $4.2M $4.2M 2022 −21% 2023: $4.1M $4.1M 2023 −2% Total liabilities4 5 8 6 7 3 $11.8M in 2023+39% since 2017 0 $5.0M $10.0M $15.0M 2017: $8.5M $8.5M 2017 2018: $8.2M $8.2M 2018 −4% 2019: $8.5M $8.5M 2019 +3% 2020: $9.7M $9.7M 2020 +15% 2021: $7.7M $7.7M 2021 −21% 2022: $9.0M $9.0M 2022 +18% 2023: $11.8M $11.8M 2023 +30% Shareholders’ equity5 8 6 7 3 -$7.7M in 2023+22% since 2017 -$10.0M -$7.5M -$5.0M -$2.5M 0 $2.5M 2017: -$6.3M -$6.3M 2017 2018: -$6.1M -$6.1M 2018 −3% 2019: -$6.8M -$6.8M 2019 +11% 2020: $1.6M $1.6M 2020 2021: -$2.3M -$2.3M 2021 2022: -$4.8M -$4.8M 2022 +106% 2023: -$7.7M -$7.7M 2023 +59% Cash5 8 6 7 3 $156.5K in 2023−92% since 2017 0 $1.0M $2.0M $3.0M 2017: $2.1M $2.1M 2017 2018: $1.8M $1.8M 2018 −12% 2019: $511.6K $511.6K 2019 −72% 2020: $457.2K $457.2K 2020 −11% 2021: $453.0K $453.0K 2021 −1% 2022: $47.3K $47.3K 2022 −90% 2023: $156.5K $156.5K 2023 +231% Total assets9 10 $3.7M in Q2 FY2024−10% since Q1 FY2023 0 $2.0M $4.0M $6.0M Q1 FY2023: $4.1M $4.1M Q1 FY2023 Q2 FY2023: $4.1M $4.1M Q2 FY2023 +0% Q1 FY2024: $3.9M $3.9M Q1 FY2024 −5% Q2 FY2024: $3.7M $3.7M Q2 FY2024 −5% Total liabilities9 10 $13.3M in Q2 FY2024+13% since Q1 FY2023 0 $5.0M $10.0M $15.0M Q1 FY2023: $11.8M $11.8M Q1 FY2023 Q2 FY2023: $11.8M $11.8M Q2 FY2023 +0% Q1 FY2024: $11.4M $11.4M Q1 FY2024 −3% Q2 FY2024: $13.3M $13.3M Q2 FY2024 +17% Shareholders’ equity9 10 -$9.5M in Q2 FY2024+25% since Q1 FY2023 -$10.0M -$7.5M -$5.0M -$2.5M 0 Q1 FY2023: -$7.7M -$7.7M Q1 FY2023 Q2 FY2023: -$7.7M -$7.7M Q2 FY2023 +0% Q1 FY2024: -$7.4M -$7.4M Q1 FY2024 −3% Q2 FY2024: -$7.4M -$7.4M Q2 FY2024 +0% Q2 FY2024: -$9.5M -$9.5M Q2 FY2024 +28% Cash9 10 $6.0K in Q2 FY2024−96% since Q1 FY2023 0 $50.0K $100.0K $150.0K $200.0K Q1 FY2023: $156.5K $156.5K Q1 FY2023 Q2 FY2023: $156.5K $156.5K Q2 FY2023 +0% Q1 FY2024: $96.7K $96.7K Q1 FY2024 −38% Q2 FY2024: $6.0K $6.0K Q2 FY2024 −94% Long-term debt10 $6.0M in Q2 FY2024+22% since Q2 FY2023 0 $2.0M $4.0M $6.0M Q2 FY2023: $4.9M $4.9M Q2 FY2023 Q2 FY2024: $6.0M $6.0M Q2 FY2024 +22% Fiscal year 2017 2018 2019 2020 2021 2022 2023 Cash $2.1M5 $1.8M8 $511.6K6 $457.2K6 $453.0K7 $47.3K7 $156.5K3 Current assets $2.1M4 $2.0M5 $1.6M8 $713.1K6 $636.6K7 $104.0K3 $156.5K3 Total assets $2.2M4 $2.1M5 $1.7M8 $11.3M6 $5.3M7 $4.2M3 $4.1M3 Current liabilities $7.7M4 $3.3M5 $3.4M8 $1.5M6 $2.6M7 $3.4M3 $6.0M3 Total liabilities $8.5M4 $8.2M5 $8.5M8 $9.7M6 $7.7M7 $9.0M3 $11.8M3 Shareholders’ equity -$6.3M5 -$6.1M8 -$6.8M6 $1.6M7 -$2.3M3 -$4.8M3 -$7.7M3 Shares outstanding 54.6M shares4 59.6M shares5 64.9M shares8 125.3M shares6 138.1M shares7 192.4M shares3 245.9M shares3
Cash from operations8 6 7 3 -$1.0M in 2023−80% since 2019 -$6.0M -$4.0M -$2.0M 0 2019: -$5.0M -$5.0M 2019 2020: -$3.2M -$3.2M 2020 −36% 2021: -$2.5M -$2.5M 2021 −23% 2022: -$2.0M -$2.0M 2022 −18% 2023: -$1.0M -$1.0M 2023 −50% Capital spending6 7 3 $0 in 20230 $25.0K $50.0K $75.0K $100.0K 2020: $97.3K $97.3K 2020 2021: $40.5K $40.5K 2021 −58% 2022: $8.7K $8.7K 2022 −78% 2023: $0 $0 2023 Free cash flow6 7 3 -$1.0M in 2023−69% since 2020 -$4.0M -$3.0M -$2.0M -$1.0M 0 2020: -$3.3M -$3.3M 2020 2021: -$2.5M -$2.5M 2021 −24% 2022: -$2.1M -$2.1M 2022 −19% 2023: -$1.0M -$1.0M 2023 −50% Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Fiscal year 2017 2018 2019 2020 2021 2022 2023 Cash from operations -$5.0M8 -$3.2M6 -$2.5M7 -$2.0M3 -$1.0M3 Capital spending $97.3K6 $40.5K7 $8.7K3 $03 Free cash flow -$3.3M -$2.5M -$2.1M -$1.0M
Compare AXIM BIOTECHNOLOGIES, INC. with another company
Former names
AXIM INTERNATIONAL INC. Mar 10, 2011 to Aug 13, 20142
Recent filings
Dec 6, 2024 15-12G AXIM BIOTECHNOLOGIES, INC. FORM 15-12GNov 13, 2024 NT 10-Q AXIM BIOTECHNOLOGIES, INC._FORM NT 10-QOct 15, 2024 8-K AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILINGOct 15, 2024 4 PRIMARY DOCUMENTAug 19, 2024 10-Q Aug 13, 2024 NT 10-Q AXIM BIOTECHNOLOGIES FORM 12B-25May 22, 2024 10-Q/A May 20, 2024 10-Q May 15, 2024 NT 10-Q AXIM BIOTECHNOLOGIES FORM 12B-25Apr 16, 2024 10-K Apr 1, 2024 NT 10-K AXIM BIOTECHNOLOGIES, INC. - NT 10KMar 21, 2024 8-K AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILINGMar 19, 2024 4 PRIMARY DOCUMENTMar 19, 2024 4 PRIMARY DOCUMENTMar 19, 2024 4 PRIMARY DOCUMENTEvery filing from the last three years, summarized . The full record is on SEC EDGAR.1
